Abstract: The use of a compound of the formula: ##STR1## in which X is --O-- or --NH--, or a pharmaceutically-acceptable acid addition salt thereof, in the treatment of atherosclerosis.
Abstract: Compounds for treating cardiovascular or circulatory disorders of the formula ##STR1## and pharmaceutically acceptable salts thereof wherein R.sup.1, R.sup.2, R.sup.3, R.sup.7, Ar.sup.1, Ar.sup.2, X, Y, and n are defined herein.
Type:
Grant
Filed:
May 26, 1995
Date of Patent:
February 11, 1997
Assignee:
Beiersdorf-Lilly GmbH
Inventors:
Gerd R uhter, Theo Schotten, Wolfgang Stenzel, Michael Paal
Abstract: Compounds having the formula ##STR1## and the other variables are as defined herein, and are indicated for use in the treatment and prophylaxis of, for example, hypertension, congestive heart failure, ocular hypertension, renal failure, and CNS disorders, or are intermediates thereto.
Type:
Grant
Filed:
May 26, 1995
Date of Patent:
February 11, 1997
Assignee:
Beiersdorf-Lilly GmbH
Inventors:
Gerd R uhter, Theo Schotten, Wolfgang Stenzel, Michael Paal